BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Glenmark Pharmaceuticals Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
532296
ISIN Demat
INE935A01035
Book Value (Rs)
848.3143291
NSE Symbol
GLENMARK
Divident Yield %
0.11
Market Cap
(Rs In Cr.)
64,851
P/E (TTM)
43.71
EPS (TTM)
52.57
Face Value
(Rs)
1
Back
Glenmark Pharmaceuticals consolidated net profit rises 15.88% in the December 2025 quarter
31-Jan-26   Hrs IST

Net profit of Glenmark Pharmaceuticals rose 15.88% to Rs 403.21 crore in the quarter ended December 2025 as against Rs 347.96 crore during the previous quarter ended December 2024. Sales rose 17.75% to Rs 3888.00 crore in the quarter ended December 2025 as against Rs 3301.90 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales3888.003301.90 18
OPM %22.3718.18 -
PBDT872.79579.06 51
PBT718.34456.33 57
NP403.21347.96 16

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)